Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers

Bioconjugate Chemistry

Volumn 9, Issue 6, 1998, Pages 813-825

  Wilbur, D Scott ^a   Pathare, Pradip M ^a   Hamlin, Donald K ^a   Buhler, Kent R ^a   Vessella, Robert L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; COENZYMES; DISEASES; MONOCLONAL ANTIBODIES; POLYSTYRENES; RADIOACTIVITY; STARS;

ANTIBODY CONJUGATE; BIOTIN MOIETY; BIOTINYLATIONS; CANCER CELLS; DENDRIMER GENERATION; IN-VITRO ASSAYS; MULTIMERS; RADIOIODINATION; STARBURST DENDRIMER; STREPTAVIDIN;

DENDRIMERS;

EID: 0032212052     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc980055e     Document Type: Article

References (46)

1. Goodwin, D. A., Meares, C. F., McTigue, M., and David, G. S. (1986) Monoclonal Antibody Hapten Radiopharmaceutical Delivery. Nucl. Med. Commun. 7, 569-580.
2. Hnatowich, D. J., Virzi, F., and Rusckowski, M. (1987) Investigations of Avidin and Biotin for Imaging Applications. J. Nucl. Med. 28, 1294-1302.
3. Paganelli, G., Riva, P., Deleide, G., Clivio, A., Chiolerio, F., Scassellati, G. A., Malcovati, M., and Siccardi, A. G. (1988) In Vivo Labeling of Biotinylated Monoclonal Antibodies by Radioactive Avidin: A Strategy to Increase Tumor Radiolocalization. Int. J. Cancer 2, 121-125.
4. Goodwin, D. A. (1995) Tumor Pretargeting: Almost the Bottom Line. J. Nucl. Med. 36, 876-879.
5. Goodwin, D. A., and Meares, C. F. (1997) Pretargeting: General Principles. Cancer (Suppl.) 80, 2675-2680.
6. Stoldt, H. S., Aftab, F., Chinol, M., Paganelli, G., Luca, F., Testori, A., and Geraghty, J. G. (1997) Pretargeting Strategies for Radio-immunoguided Tumour Localisation and Therapy. Eur. J. Cancer 33, 186-192.
7. Kassis, A. I., Jones, P. L., Matalka, K. Z., and Adelstein, S. J. (1996) Antibody-Dependent Signal Amplification in Tumor Xenografts after Pretreatment with Biotinylated Monoclonal Antibody and Avidin or Streptavidin. J. Nucl. Med. 37, 343-352.
8. Paganelli, G., Pervez, S., Siccardi, A. G., Rowlinson, G., Deleide, G., Chiolerio, F., Malcovati, M., Scassellati, G. A., and Epenetos, A. A. (1990) Intraperitoneal Radio-Localization of Tumors Pre-Targeted by Biotinylated Monoclonal Antibodies. Int. J. Cancer 45, 1184-1189.
9. Kalofonos, H. P., Rusckowski, M., Siebecker, D. A., Sivolapenko, G. B., Snook, D., Lavender, J. P., Epenetos, A. A., and Hnatowich, D. J. (1990) Imaging of Tumor in Patients with Indium-111-Labeled Biotin and Streptavidin-Conjugated Antibodies: Preliminary Communication. J. Nucl. Med. 31, 1791-1796.
10. del Rosario, R. B., and Wahl, R. L. (1993) Biotinylated Iodo-Polylysine for Pretargeted Radiation Delivery. J. Nucl. Med. 34, 1147-1151.
11. Khawli, L. A., Alauddin, M. M., Miller, G. K., and Epstein, A. L. (1993) Improved Immunotargeting of Tumors with Biotinylated Monoclonal Antibodies and Radiolabeled Streptavidin. Antibody, Immunoconjugates, Radiopharm. 6, 13-27.
12. 111In-Labeled Biotin. Antibody, Immunoconjugates, Radiopharm. 6, 97-109.
13. Saga, T., Weinstein, J. N., Jeong, J. M., Heya, T., Lee, J. T., Le, N., Paik, C. H., Sung, C., and Neumann, R. D. (1994) Two-Step Targeting of Experimental Lung Metastases with Biotinylated Antibody and Radiolabeled Streptavidin. Cancer Res. 54, 2160-2165.
14. Ngai, W. M., Reilly, R. M., Polihronis, J., and Shptiz, B. (1995) In Vitro and In Vivo Evaluation of Streptavidin Immunoconjugates of the Second Generation TAG-72 Monoclonal Antibody CC49. Nucl. Med. Biol. 22, 77-86.
15. Wilbur, D. S., Hamlin, D. K., Vessella, R. L., Stray, J., Buhler, K. R., Stayton, P., Klumb, L., Pathare, P. M., and Weerawarna, S. A. (1996) Antibody Fragments in Tumor Pretargeting. Evaluation of Biotinylated Fab′ Co-localization with Recombinant Streptavidin and Avidin. Bioconjugate Chem. 7, 689-702.
16. 111In-DTPA-Biocytin. Nucl. Med. Biol. 23, 459-466.
17. Sharkey, R. M., Karacay, H., Griffiths, G. L., Behr, T. M., Blumenthal, R. D., Mattes, M. J., Hansen, H. J., and Goldenberg, D. M. (1997) Development of a Streptavidin-Anti-Carcinoembryonic Antigen Antibody, Radiolabeled Biotin Pretargeting Method for Radioimmunotherapy of Colon Cancer. Studies in a Human Colon Cancer Xenograft Model. Bioconjugate Chem. 8, 595-604.
18. Green, N. M. (1963) Avidin. Biochem. J. 89, 609-620.
19. Green, N. M. (1975) Avidin. Adv. Protein Chem. 29, 85-133.
20. Green, N. M. (1990) Avidin and Streptavidin. Methods Enzymol. 184, 51-67.
21. Paganelli, G., Malcovati, M., and Fazio, F. (1991) Monoclonal Antibody pretargetting techniques for tumour localization: the avidin-biotin system. Nucl. Med. Commun. 12, 211-234.
22. Wilbur, D. S., Pathare, P. M., Hamlin, D. K., and Weerawarna, S. A. (1997) Biotin Reagents for Antibody Pretargeting. 2. Synthesis and in Vitro Evaluation of Biotin Dimers and Trimers for Cross-Linking of Streptavidin. Bioconjugate Chem. 8, 819-832.
23. Klibanov, A. L., Martynov, A. V., Slinkin, M. A., Sakharov, I. Y., Smirnov, M. D., Muzykantov, V. R., Danilov, S. M., and Torchilin, V. P. (1988) Blood Clearance of Radiolabeled Antibody: Enhancement by Lactosamination and Treatment with Biotin-Avidin or Anti-Mouse IgG Antibodies. J. Nucl. Med. 29, 1951-1956.
24. Sinitsyn, V. V., Mamontova, A. G., Checkneva, Y. Y. S., Alexander A., and Domogatsky, S. P. (1989) Rapid Blood Clearance of Biotinylated IgG After Infusion of Avidin. J. Nucl. Med. 30, 66-69.
25. Marshall, D., Pedley, R. B., Boden, J. A., Boden, R., and Begent, R. H. J. (1994) Clearance of Circulating Radio-Antibodies Using Streptavidin or Second Antibodies in a Xenograft Model. Br. J. Cancer 69, 502-507.
26. Kobayashi, H., Sakahara, H., Hosono, M., Yao, Z.-S., Toyama, S., Endo, K., and Konishi, J. (1994) Improved Clearance of Radiolabeled Biotinylated Monoclonal Antibody Following the Infusion of Avidin as a "Chase" without Decreased Accumulation in the Target Tumor. J. Nucl. Med. 35, 1677-1684.
27. Marshall, D., Pedley, R. B., Melton, R. G., Boden, J. A., Boden, R., and Begent, R. H. J. (1995) Galactosylated Streptavidin for Improved Clearance of Biotinylated Intact and F(ab′)2 Fragments of an Anti-Tumour Antibody. Br. J. Cancer 71, 18-24.
28. Rosebrough, S. F., and Hashmi, M. (1996) Galactose-Modified Streptavidin-GC4 Antifibrin Monoclonal Antibody Conjugates: Application for Two-Step Thrombus/Embolus Imaging. J. Pharmacol. Exp. Ther. 276, 770-775.
29. Tomalia, D. A., Naylor, A. M., and Goddard, W. A., III (1990) Starburst Dendrimers: Molecular-Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter. Angew. Chem., Int. Ed. Eng. 29, 138-175.
30. Tomalia, D. A. (1993) StarburstTM/Cascade Dendrimers: Fundamental Building Blocks for a New Nanoscopic Chemistry Set. Aldrichim. Acta 26, 91-101.
31. Tomalia, D. A., and Durst, H. D. (1993) Genealogically Directed Synthesis: Starburst/Cascade Dendrimers and Hyperbranched Structures. Topics Curr. Chem. 165, 193-313.
32. Wilbur, D. S., Hamlin, D. K., Pathare, P. M., and Weerawarna, S. A. (1997) Biotin Reagents for Antibody Pretargeting. Synthesis, Radioiodination and In Vitro Evaluation of Water Soluble, Biotinidase Resistant Biotin Derivatives. Bioconjugate Chem. 8, 572-584.
33. Rosebrough, S. F. (1993) Plasma Stability and Pharmacokinetics of Radiolabeled Deferoxamine-Biotin Derivatives. J. Pharmacol. Exp. Ther. 265, 408-415.
34. Axworthy, D. B., Theodore, L. J., Gustavson, L. M., and Reno, J. M. (1997) Biotinidase-Resistant Biotin-DOTA Conjugates. United States Patent Number 5,608,060.
35. Wilbur, D. S., Hamlin, D. K., Buhler, K. R., Pathare, P. M., Vessella, R. L., Stayton, P. S., and To, R. (1998) Streptavidin in Antibody Pretargeting. 2. Evaluation of Methods to Decrease Localization of Streptavidin to Kidney while Retaining its Tumor Binding Capacity. Bioconjugate Chem. 9, 322-330.
36. Wilbur, D. S., Hadley, S. W., Hylarides, M. D., Abrams, P. G., Beaumier, P. A., Morgan, A. C., Reno, J. M., and Fritzberg, A. R. (1989) Development of a Stable Radioiodinating Reagent to Label Monoclonal Antibodies for Radiotherapy of Cancer. J. Nucl. Med. 30, 216-226.
37. Seitz, O., and Kunz, H. (1997) HYCRON, an Allylic Anchor for High-Efficiency Solid-Phase Synthesis of Protected Peptides and Glycopeptides. J. Org. Chem. 62, 813-826.
38. Wilbur, D. S., Stayton, P. S., To, R., Buhler, K. R., Klumb, L. A., Hamlin, D. K, Stray, J. E., and Vessella, R. L. (1998) Streptavidin in Antibody Pretargeting. Comparison of a Recombinant Streptavidin with Two Streptavidin Mutant Proteins and Two Commercially Available Streptavidin Proteins. Bioconjugate Chem. 9, 100-107.
39. Fritzberg, A. R., Beaumier, P. L., Bottino, B. J., and Reno, J. M. (1994) Approaches to improved antibody-and peptide-mediated targeting for imaging and therapy of cancer. J. Controlled Release 28, 167-173.
40. Wilchek, M., and Bayer, E. A. (1990) Biotin-Containing Reagents. Methods Enzymol. 184, 123-138.
41. Bayer, E. A., and Wilchek, M. (1990) Protein Biotinylation. Methods Enzymol. 184, 138-161.
42. Hymes, J., Fleischhauer, K., and Wolf, B. (1997) Biotinidase in Serum and Tissues. Methods Enzymol. 279, 422-434.
43. Pispa, J. (1965) Animal Biotinidase. Ann. Med. Exp. Biol. Fenniae 43, 3-40.
44. Wolf, B., Hymes, J., and Heard, G. S. (1990) Biotinidase. Methods Enzymol. 184, 103-111.
45. Chauhan, J., Ebrahim, H., Bhullar, R. P., and Dakshinamurti, K. (1985) Human Serum Biotinidase. Ann. N. Y. Acad. Sci. 447, 386-388.
46. Wilbur, D. S., Pathare, P. M., Hamlin, D. K., Stayton, P. S., To, R., Klumb, L., Buhler, K. R., and Vessella, R. L. (1998) Development of New Reagents for Pretargeting. Genet. Anal.: Biomol. Eng. (submitted for publication).